Hangzhou Tigermed Consulting Strategic Asset Allocation Index
Hangzhou Tigermed Consulting strategic asset allocation index. Hangzhou Tigermed Consulting (300347) has a Strategic Asset Allocation Index of 5.7% as of June 2023. Strategic assets (PP&E of CN¥1.37 Billion plus long-term investments of CN¥-) total CN¥1.37 Billion, measured against net assets of CN¥23.96 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Hangzhou Tigermed Consulting balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Hangzhou Tigermed Consulting (2009–2022)
Strategic asset allocation index of Hangzhou Tigermed Consulting from 2009 to 2022. This chart shows how Hangzhou Tigermed Consulting's Strategic Asset Allocation Index has evolved across 14 annual periods from 2009 to 2022. As of June 2023, the index stands at 5.7%, representing strategic assets of CN¥1.37 Billion against net assets of CN¥23.96 Billion CNY. Check 300347 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Hangzhou Tigermed Consulting Strategic Asset Allocation Index by Year (2009–2022)
Hangzhou Tigermed Consulting strategic asset allocation index by year from 2009 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Hangzhou Tigermed Consulting from 2009 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Hangzhou Tigermed Consulting market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 5.8% | CN¥1.33 Billion | CN¥1.33 Billion | CN¥- | CN¥22.68 Billion | ▲ +0.4 pp |
| 2021 | 5.5% | CN¥1.12 Billion | CN¥1.12 Billion | CN¥- | CN¥20.61 Billion | ▲ +1.6 pp |
| 2020 | 3.8% | CN¥682.67 Million | CN¥682.67 Million | CN¥- | CN¥17.86 Billion | ▼ -3.9 pp |
| 2019 | 7.7% | CN¥425.81 Million | CN¥425.81 Million | CN¥- | CN¥5.52 Billion | ▼ -40.6 pp |
| 2018 | 48.3% | CN¥1.58 Billion | CN¥254.89 Million | CN¥1.33 Billion | CN¥3.27 Billion | ▲ +9.6 pp |
| 2017 | 38.7% | CN¥1.08 Billion | CN¥201.96 Million | CN¥882.60 Million | CN¥2.80 Billion | ▲ +2.8 pp |
| 2016 | 35.9% | CN¥661.11 Million | CN¥200.33 Million | CN¥460.78 Million | CN¥1.84 Billion | ▼ -0.4 pp |
| 2015 | 36.4% | CN¥387.73 Million | CN¥194.04 Million | CN¥193.69 Million | CN¥1.07 Billion | ▲ +20.0 pp |
| 2014 | 16.4% | CN¥150.54 Million | CN¥150.54 Million | CN¥- | CN¥916.90 Million | ▲ +5.7 pp |
| 2013 | 10.7% | CN¥81.06 Million | CN¥81.06 Million | CN¥- | CN¥755.14 Million | ▲ +2.6 pp |
| 2012 | 8.2% | CN¥56.60 Million | CN¥56.60 Million | CN¥- | CN¥694.32 Million | ▼ -10.9 pp |
| 2011 | 19.0% | CN¥27.79 Million | CN¥27.79 Million | CN¥- | CN¥146.03 Million | ▲ +1.8 pp |
| 2010 | 17.2% | CN¥16.47 Million | CN¥16.47 Million | CN¥- | CN¥95.79 Million | ▼ -21.9 pp |
| 2009 | 39.1% | CN¥17.32 Million | CN¥17.32 Million | CN¥- | CN¥44.26 Million | — |